{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T17:20:40Z","timestamp":1790961640974,"version":"4.1.0"},"reference-count":64,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T00:00:00Z","timestamp":1770163200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","rbmojournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reproductive BioMedicine Online"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.rbmo.2026.105541","type":"journal-article","created":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T16:38:33Z","timestamp":1770223113000},"page":"105541","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Management of moderate and severe ovarian hyperstimulation syndrome: a Canadian Fertility and Andrology Society clinical practice guideline"],"prefix":"10.1016","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8635-582X","authenticated-orcid":false,"given":"William","family":"Buckett","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Sylvestre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neal","family":"Mahutte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Min","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeff","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio","family":"Saumet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Shapiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sony","family":"Sierra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria P.","family":"Velez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rbmo.2026.105541_bib0001","series-title":"StatPearls [Internet]","article-title":"Normal and abnormal urine output and interpretation","author":"Al-Kazwini","year":"2025"},{"key":"10.1016\/j.rbmo.2026.105541_bib0002","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.ejogrb.2022.04.001","article-title":"Association between hospital treatment volume and major complications in ovarian hyperstimulation syndrome","volume":"272","author":"Bainvoll","year":"2022","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"10.1016\/j.rbmo.2026.105541_bib0003","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1093\/oxfordjournals.humrep.a137103","article-title":"Acute prerenal failure and liver dysfunction in a patient with severe ovarian hyperstimulation syndrome","volume":"5","author":"Balasch","year":"1990","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.rbmo.2026.105541_bib0004","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1093\/humrep\/deq080","article-title":"Maternal death related to IVF in the Netherlands 1984\u20132008","volume":"25","author":"Braat","year":"2010","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.rbmo.2026.105541_bib0005","unstructured":"Canadian Assisted Reproductive Technologies Register. CARTR reports 2015\u20132025. Accessed CFAS 1 May, 2025. https:\/\/cfas.ca\/cgi\/page.cgi\/cartr-annual-reports.html"},{"issue":"2","key":"10.1016\/j.rbmo.2026.105541_bib0006","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1080\/03009734.2020.1737599","article-title":"Gonadotropin-releasing hormone agonist ovulation trigger \u2013 beyond OHSS prevention","volume":"125","author":"Castillo","year":"2020","journal-title":"Ups. J. Med. Sci."},{"key":"10.1016\/j.rbmo.2026.105541_bib0007","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/GCO.0b013e328329c2b8","article-title":"The \u2018ART\u2019 of thrombosis: A review of arterial and venous thrombosis in assisted reproductive technology","volume":"21","author":"Chan","year":"2009","journal-title":"Curr. Opin. Obstet. Gynecol."},{"key":"10.1016\/j.rbmo.2026.105541_bib0008","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.tjog.2011.01.014","article-title":"Update on management of ovarian hyperstimulation syndrome","volume":"50","author":"Chen","year":"2011","journal-title":"Taiwan J. Obstet. Gynecol."},{"key":"10.1016\/j.rbmo.2026.105541_bib0009","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ejogrb.2018.03.028","article-title":"Is thromboprophylaxis cost effective in ovarian hyperstimulation syndrome: A systematic review and cost analysis","volume":"224","author":"Comerford Wormer","year":"2018","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"10.1016\/j.rbmo.2026.105541_bib0010","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12920-023-01473-3","article-title":"Spontaneous and iatrogenic ovarian hyperstimulation syndrome in the absence of FSHR mutations: a case report of two unexpected cases","volume":"16","author":"Daolio","year":"2023","journal-title":"BMC Med. Genomics."},{"key":"10.1016\/j.rbmo.2026.105541_bib0011","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S0015-0282(16)56997-0","article-title":"Angiotensin II immunoreactivity is elevated in ascites during severe ovarian hyperstimulation syndrome: implications for pathophysiology and clinical management","volume":"62","author":"Delbaere","year":"1994","journal-title":"Fertil. Steril."},{"issue":"2","key":"10.1016\/j.rbmo.2026.105541_bib0012","doi-asserted-by":"crossref","first-page":"hoaa009","DOI":"10.1093\/hropen\/hoaa009","article-title":"ESHRE guideline: ovarian stimulation for IVF\/ICSI","volume":"2020","author":"Bosch","year":"2020","journal-title":"Hum. Reprod. Open."},{"key":"10.1016\/j.rbmo.2026.105541_bib0013","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ejogrb.2019.02.034","article-title":"Arterial and venous complications after fertility treatment: A French nationwide cohort study","volume":"237","author":"Filipovic-Pierucci","year":"2019","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"10.1016\/j.rbmo.2026.105541_bib0014","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/S0015-0282(99)00606-8","article-title":"An ounce of prevention: outpatient management of the ovarian hyperstimulation syndrome","volume":"73","author":"Fluker","year":"2000","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.rbmo.2026.105541_bib0015","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1080\/14647273.2017.1331048","article-title":"Outpatient management of severe ovarian hyperstimulation syndrome: a systematic review and a review of existing guidelines","volume":"21","author":"Gebril","year":"2018","journal-title":"Hum. Fertil. (Camb)."},{"key":"10.1016\/j.rbmo.2026.105541_bib0016","unstructured":"GRADEpro. 2023. GRADEpro Guideline Development Tool [Software]. McMaster University and Evidence Prime. Available from gradepro.org."},{"key":"10.1016\/j.rbmo.2026.105541_bib0017","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.3390\/jcm14041053","article-title":"Risk of thrombosis in women undergoing in vitro fertilization: a narrative review","volume":"14","author":"Grandone","year":"2025","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.rbmo.2026.105541_bib0018","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1757-2215-7-35","article-title":"HCG (1500IU) administration on day 3 after oocytes retrieval, following GnRH-agonist trigger for final follicular maturation, results in high sufficient mid luteal progesterone levels \u2013 a proof of concept","volume":"7","author":"Haas","year":"2014","journal-title":"J. Ovarian. Res."},{"key":"10.1016\/j.rbmo.2026.105541_bib0019","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s00404-014-3210-z","article-title":"Pregnancy outcome in women exposed to dopamine agonists during pregnancy: a pharmacoepidemiology study in EFEMERIS database","volume":"290","author":"Hurault-Delarue","year":"2014","journal-title":"Arch. Gynecol. Obstet."},{"key":"10.1016\/j.rbmo.2026.105541_bib0020","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.fertnstert.2012.05.042","article-title":"Prediction of in vitro fertilization outcome at different antral follicle count thresholds in a prospective cohort of 1,012 women","volume":"98","author":"Jayaprakasan","year":"2012","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.rbmo.2026.105541_bib0021","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/ajo.12389","article-title":"RANZCOG CREI Consensus Statement on treatment of ovarian hyperstimulation syndrome","volume":"55","author":"Kwik","year":"2015","journal-title":"Aust. N.Z. J. Obstet. Gynaecol."},{"issue":"5","key":"10.1016\/j.rbmo.2026.105541_bib0022","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1007\/s12325-023-02481-6","article-title":"Non-steroidal anti-inflammatory drugs: clinical implications, renal impairment risks, and AKI","volume":"40","author":"LaForge","year":"2023","journal-title":"Adv. Ther."},{"key":"10.1016\/j.rbmo.2026.105541_bib0023","doi-asserted-by":"crossref","first-page":"449","DOI":"10.5468\/ogs.2017.60.5.449","article-title":"Gonadotropin releasing hormone antagonist administration for treatment of early type severe ovarian hyperstimulation syndrome: a case series","volume":"60","author":"Lee","year":"2017","journal-title":"Obstet. Gynecol. Sci."},{"key":"10.1016\/j.rbmo.2026.105541_bib0024","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1093\/humrep\/deab147","article-title":"Overview of hospitalizations in women undergoing oocyte retrieval for ART in the French national health data system","volume":"36","author":"Lemardeley","year":"2021","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.rbmo.2026.105541_bib0025","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1080\/09513590.2022.2122429","article-title":"Severe ovarian hyperstimulation syndrome induced by clomiphene: a case report","volume":"38","author":"Li","year":"2022","journal-title":"Gynecol. Endocrinol."},{"key":"10.1016\/j.rbmo.2026.105541_bib0026","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1023\/A:1014828027282","article-title":"Aggressive outpatient treatment of ovarian hyperstimulation syndrome with ascites using transvaginal culdocentesis and intravenous albumin minimizes hospitalization","volume":"19","author":"Lincoln","year":"2002","journal-title":"J. Assist. Reprod. Genet."},{"key":"10.1016\/j.rbmo.2026.105541_bib0027","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.ajog.2016.08.018","article-title":"Effect of letrozole on moderate and severe early-onset ovarian hyperstimulation syndrome in high-risk women: a prospective randomized trial","volume":"216","author":"Mai","year":"2017","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.rbmo.2026.105541_bib0028","first-page":"557","article-title":"High dose cabergoline in management of bilateral ovarian hyperstimulation syndrome: a case report","volume":"14","author":"Manalai","year":"2021","journal-title":"Int. Med. Case Rep. J."},{"key":"10.1016\/j.rbmo.2026.105541_bib0029","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/01.AOG.0000129956.97012.0d","article-title":"Renal blood flow alteration after paracentesis in women with ovarian hyperstimulation","volume":"104","author":"Maslovitz","year":"2004","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.rbmo.2026.105541_bib0030","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S0015-0282(00)00492-1","article-title":"Distinction between early and late ovarian hyperstimulation syndrome","volume":"73","author":"Mathur","year":"2000","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.rbmo.2026.105541_bib0031","first-page":"103","article-title":"Preconception use of pain-relievers and time-to-pregnancy: a prospective cohort study","volume":"32","author":"McInerney","year":"2017","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.rbmo.2026.105541_bib0032","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1007\/s00404-022-06717-8","article-title":"Gonadotropin releasing hormone (GnRH) antagonist administration to decrease the risk of ovarian hyperstimulation syndrome in GNRH agonist cycles triggered with human chorionic gonadotropin","volume":"306","author":"Mills","year":"2022","journal-title":"Arch. Gynecol. Obstet."},{"key":"10.1016\/j.rbmo.2026.105541_bib0033","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.mjafi.2017.04.006","article-title":"Severe ovarian hyperstimulation syndrome: Can we eliminate it through a multipronged approach?","volume":"74","author":"Naredi","year":"2018","journal-title":"Med. J. Armed Forces India"},{"key":"10.1016\/j.rbmo.2026.105541_bib0034","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0015-0282(16)55188-7","article-title":"Ovarian hyperstimulation syndrome in novel reproductive technologies: prevention and treatment","volume":"58","author":"Navot","year":"1992","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.rbmo.2026.105541_bib0035","doi-asserted-by":"crossref","first-page":"e2464","DOI":"10.1002\/bdr2.2464","article-title":"Cabergoline use and pregnancy outcomes: a systematic review","volume":"117","author":"Otis","year":"2025","journal-title":"Birth Defects Research"},{"key":"10.1016\/j.rbmo.2026.105541_bib0036","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1093\/humrep\/deh638","article-title":"Early and late ovarian hyperstimulation syndrome: early pregnancy outcome and profile","volume":"20","author":"Papanikolaou","year":"2005","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.rbmo.2026.105541_bib0037","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.fertnstert.2023.11.013","article-title":"Prevention of moderate and severe ovarian hyperstimulation syndrome: a guideline","volume":"121","year":"2024","journal-title":"Fertil. Steril."},{"issue":"supp3","key":"10.1016\/j.rbmo.2026.105541_bib0038","first-page":"S188","article-title":"Ovarian hyperstimulation syndrome","volume":"90","year":"2008","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.rbmo.2026.105541_bib0039","doi-asserted-by":"crossref","first-page":"379","DOI":"10.3109\/01443615.2012.663422","article-title":"Multiple transvaginal ascitic fluid aspirations improves the clinical and reproductive outcome in patients undergoing in vitro fertilisation treatment complicated by severe early ovarian hyperstimulation syndrome","volume":"32","author":"Qublan","year":"2012","journal-title":"J. Obstet. Gynaecol."},{"key":"10.1016\/j.rbmo.2026.105541_bib0040","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1093\/humrep\/12.12.2614","article-title":"A novel approach to the treatment of ascites associated with ovarian hyperstimulation syndrome","volume":"12","author":"Rahami","year":"1997","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.rbmo.2026.105541_bib0041","doi-asserted-by":"crossref","first-page":"1169.e15","DOI":"10.1016\/j.fertnstert.2009.05.062","article-title":"Treatment of ovarian hyperstimulation syndrome using a dopamine agonist and gonadotropin releasing hormone antagonist: a case series","volume":"92","author":"Rollene","year":"2009","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.rbmo.2026.105541_bib0042","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.fertnstert.2011.10.038","article-title":"Venous thromboembolism in relation to in vitro fertilization: an approach to determining the incidence and increase in risk in successful cycles","volume":"97","author":"Rova","year":"2012","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.rbmo.2026.105541_bib0043","unstructured":"Royal College of Obstetricians and Gynaecologists. 2015. Reducing the Risk of Venous Thromboembolism during Pregnancy and the Puerperium. Green-top Guideline No. 37a. Retrieved from https:\/\/www.rcog.org.uk\/guidance\/browse-all-guidance\/green-top-guidelines\/reducing-the-risk-of-thrombosis-and-embolism-during-pregnancy-and-the-puerperium-green-top-guideline-no-37a\/"},{"key":"10.1016\/j.rbmo.2026.105541_bib0044","unstructured":"Royal College of Obstetricians and Gynaecologists, 2016. The management of ovarian hyperstimulation syndrome. Green-top Guideline No. 5. (First edition 2006; Third edition 2016). Royal College of Obstetrician and Gynaecologists Retrieved from https:\/\/www.rcog.org.uk\/guidance\/browse-all-guidance\/green-top-guidelines\/the-management-of-ovarian-hyperstimulation-syndrome-green-top-guideline-no-5\/. (Accessed 1 May, 2025)."},{"key":"10.1016\/j.rbmo.2026.105541_bib0045","doi-asserted-by":"crossref","first-page":"2808","DOI":"10.1093\/humrep\/deaa226","article-title":"The freeze-all strategy versus agonist triggering with low-dose hCG for luteal phase support in IVF\/ICSI for high responders: a randomized controlled trial","volume":"35","author":"Santos-Ribeiro","year":"2020","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.rbmo.2026.105541_bib0046","unstructured":"Society for Assisted Reproductive Technology \u2013 Clinic Outcome Reporting System.) National Summary Reports. Accessed 1 May, 2025. https:\/\/www.sartcorsonline.com\/rptcsr_publicmultyear.aspx"},{"key":"10.1016\/j.rbmo.2026.105541_bib0047","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/00006250-197507000-00004","article-title":"Ovarian hyperstimulation syndrome","volume":"46","author":"Schenker","year":"1975","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.rbmo.2026.105541_bib0048","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ajem.2022.08.014","article-title":"Emergency department utilization for ovarian hyperstimulation syndrome","volume":"60","author":"Schon","year":"2022","journal-title":"Am. J. Emerg. Med."},{"key":"10.1016\/j.rbmo.2026.105541_bib0053","unstructured":"Sch\u00fcnemann, H., Bro\u017cek, J., Guyatt, G., Oxman, A. (Eds.), 2013. GRADE handbook for grading quality of evidence and strength of recommendations. The GRADE Working Group Updated October 20132013 https:\/\/gdt.gradepro.org\/app\/handbook\/handbook.html. (Accessed 1 May, 2025)."},{"key":"10.1016\/j.rbmo.2026.105541_bib0049","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.ajog.2019.02.009","article-title":"Life-threatening complications among women with severe ovarian hyperstimulation syndrome","volume":"220","author":"Selter","year":"2019","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.rbmo.2026.105541_bib0050","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1111\/aogs.13147","article-title":"Thromboembolism and in vitro fertilization \u2013 a systematic review","volume":"96","author":"Sennstr\u00f6m","year":"2017","journal-title":"Acta. Obstet. Gynecol. Scand."},{"key":"10.1016\/j.rbmo.2026.105541_bib0051","doi-asserted-by":"crossref","first-page":"e479","DOI":"10.1016\/j.jogc.2017.09.003","article-title":"No-268-The diagnosis and management of ovarian hyperstimulation syndrome","volume":"39","author":"Shmorgun","year":"2017","journal-title":"J. Obstet. Gynaecol. Can."},{"key":"10.1016\/j.rbmo.2026.105541_bib0052","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1093\/oxfordjournals.humrep.a138601","article-title":"Day care management of severe ovarian hyperstimulation syndrome avoids hospitalization and morbidity","volume":"9","author":"Shrivastav","year":"1994","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.rbmo.2026.105541_bib0054","first-page":"1959","article-title":"Infertility, infertility treatment, and cardiovascular disease","volume":"37","author":"Smith","year":"2021","journal-title":"Can. J. Cardiol."},{"key":"10.1016\/j.rbmo.2026.105541_bib0055","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1016\/j.fertnstert.2008.09.011","article-title":"Patients with severe ovarian hyperstimulation syndrome can be managed safely with aggressive outpatient transvaginal paracentesis","volume":"92","author":"Smith","year":"2009","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.rbmo.2026.105541_bib0056","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s11102-010-0243-6","article-title":"Effects of cabergoline on pregnancy and embryo-fetal development: retrospective study on 103 pregnancies and a review of the literature","volume":"13","author":"Stalldecker","year":"2010","journal-title":"Pituitary"},{"key":"10.1016\/j.rbmo.2026.105541_bib0057","article-title":"Annual incidence of severe ovarian hyperstimulation syndrome","volume":"68","author":"Tom\u00e1s","year":"2021","journal-title":"Dan. Med. J."},{"key":"10.1016\/j.rbmo.2026.105541_bib0058","doi-asserted-by":"crossref","DOI":"10.1080\/14647273.2024.2441827","article-title":"Prevention of ovarian hyperstimulation syndrome (OHSS): British Fertility Society policy and practice guideline","volume":"28","author":"Tsampras","year":"2025","journal-title":"Hum. Fertil. (Camb)."},{"key":"10.1016\/j.rbmo.2026.105541_bib0059","first-page":"113","article-title":"Ovarian hyperstimulation syndrome following ovulation induction with human menopausal gonadotropin","volume":"29","author":"Tulandi","year":"1984","journal-title":"Int. J. Fertil."},{"key":"10.1016\/j.rbmo.2026.105541_bib0060","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s13048-015-0190-y","article-title":"Can steroidal ovarian suppression during the luteal phase after oocyte retrieval reduce the risk of severe OHSS?","volume":"8","author":"Wang","year":"2015","journal-title":"J. Ovarian Res."},{"key":"10.1016\/j.rbmo.2026.105541_bib0061","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2023-076434","article-title":"Outpatient paracentesis for the management of ovarian hyperstimulation syndrome: study protocol for the STOP-OHSS randomised controlled trial","volume":"14","author":"White","year":"2024","journal-title":"BMJ Open"},{"key":"10.1016\/j.rbmo.2026.105541_bib0062","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1007\/s10815-016-0764-7","article-title":"Micro-dose hCG as luteal phase support without exogenous progesterone administration: mathematical modelling of the hCG concentration in circulation and initial clinical experience","volume":"33","author":"Yding Andersen","year":"2016","journal-title":"J. Assist. Reprod. Genet."},{"key":"10.1016\/j.rbmo.2026.105541_bib0063","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/S1472-6483(10)61009-7","article-title":"Safety of IVF under anticoagulant therapy in patients at risk for thrombo-embolic events","volume":"12","author":"Yinon","year":"2006","journal-title":"Reprod. Biomed. Online"},{"issue":"8","key":"10.1016\/j.rbmo.2026.105541_bib0064","article-title":"Volume expanders for the prevention of ovarian hyperstimulation syndrome","volume":"2016","author":"Youssef","year":"2016","journal-title":"Cochrane Database Syst. Rev."}],"container-title":["Reproductive BioMedicine Online"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472648326000829?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472648326000829?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T23:17:31Z","timestamp":1780615051000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1472648326000829"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":64,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S1472648326000829"],"URL":"https:\/\/doi.org\/10.1016\/j.rbmo.2026.105541","relation":{},"ISSN":["1472-6483"],"issn-type":[{"value":"1472-6483","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of moderate and severe ovarian hyperstimulation syndrome: a Canadian Fertility and Andrology Society clinical practice guideline","name":"articletitle","label":"Article Title"},{"value":"Reproductive BioMedicine Online","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rbmo.2026.105541","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd on behalf of Reproductive Healthcare Ltd.","name":"copyright","label":"Copyright"}],"article-number":"105541"}}